YIXI Jinba, WANG Gaoxue, BASANG Ciren, GASONG Zhuoga, PU Zhi, CIREN Yangjin, BIAN Zhen, LIU Zhijuan, DU Juan. HPV Survey and Analysis of Women in Xizang[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0914
Citation: YIXI Jinba, WANG Gaoxue, BASANG Ciren, GASONG Zhuoga, PU Zhi, CIREN Yangjin, BIAN Zhen, LIU Zhijuan, DU Juan. HPV Survey and Analysis of Women in Xizang[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2024-0914

HPV Survey and Analysis of Women in Xizang

Funds: 

Medical Assistance Program Supported by Natural Science Foundation of Xizang Autonomous Region[XZ2023ZR-ZY02(Z)]

More Information
  • Received Date: November 13, 2024
  • Accepted Date: January 01, 2025
  • Available Online: April 16, 2025
  • Objective To investigate the positive situation of human papillomavirus (HPV) among women in high-altitude areas of Xizang. Methods Retrospective analysis of cervical swab HPV genetyping results of the outpatient, inpatient and physical examination center women in the People's Hospital of Xizang Autonomous Region from March 2019 to July 2023. Results From March 2019 to July 2023, a total of 6,498 female cervical swab HPV genotyping specimens were received, including 5,440 Xizangan female specimens and 1,058 Han female specimens. The overall HPV positive rate of women in high-altitude areas of Xizang is 19.58% (1272/6498), the HPV positive rate of Han women is 29.30% (310/1058), which is significantly higher than that of Xizangan women 17.68% (962/5440). The most common high-risk HPV genotypes are types 52, 16, 58 and 53, and the top three low-risk types of HPV are 43, 81 and 6; there are significant differences in the positive rates of high-risk HPV16, 52, 39, 66, 51, 68 and 58 among Han and Xizangan women (P<0.05). Overall, HPV single positive is the main infection form, accounting for 14.99%; HPV double positive rate is 3.71%, common HPV52 combined with other types (68/241) and HPV16 combined with other types of positive (53/241); three or more mixed positives account for 0.89%. Xizangan women show a "U" trend with a low HPV positive rate in the middle age group and a high positive rate (all greater than 30%) in the age group under 25 and over 60. Between 2019 and 2023, there was no obvious change in the overall HPV positive rate. Conclusions There is a significant difference in the HPV positive rate of Xizangan women and Han women in high-altitude areas of Xizang. The HPV infection rate is highest among Xizangan women in the age group under 25 and over 60 years old. We should focus on strengthening the vaccination of young women in high-altitude areas in Xizang, as well as the screening and diagnosis and treatment of HPV in young women and postmenopausal women.
  • Related Articles

    [1]MA Xing, LIU Chang. Prognosis and Treatment Strategies of FIGO 2018 Stage ⅢC Cervical Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1253-1260. DOI: 10.12290/xhyxzz.2024-0097
    [2]WANG Aimin, CHEN Chaojin, WANG Mujun, WANG Ruhao, LYU Jingjing. Medical Expenses for Hospitalized Patients with Cervical Cancer Before and After the Implementation of the DRG Payment Policy[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1077-1082. DOI: 10.12290/xhyxzz.2024-0475
    [3]WANG Guangyu, YAN Junfang, WANG Zhiqun, ZHANG Yu, SUN Xiansong, LI Jing, LI Wenbo, YANG Bo, ZHANG Fuquan. Locally Advanced Cervical Cancer Treated with Online Adaptive Radiotherapy: A Case Report[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(5): 1101-1105. DOI: 10.12290/xhyxzz.2023-0076
    [4]KONG Linghua, XIAO Xiaoping, WAN Ru, XIANG Yang. Clinical Application of ThinPrep Imaging System in Cervical Cytology[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(4): 613-619. DOI: 10.12290/xhyxzz.2022-0221
    [5]SU Baiyan, QI Yafei, GUAN Hui, HE Yonglan, XUE Huadan, JIN Zhengyu. Texture Analysis of Sequential Images of T2-weighted Imaging and Diffusion-weighted Imaging for Predicting the Efficacy of Chemoradiotherapy in Cervical Squamous Cell Carcinoma[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(5): 713-720. DOI: 10.12290/xhyxzz.2021-0380
    [6]Peng PENG, Yang XIANG. Reflecting the Achievements of Practice and Leading the Future Direction: Interpretation on Cervical Cancer Staging of the International Federation of Obstetrics and Gynecology in 2018[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(1): 12-15. DOI: 10.3969/j.issn.1674-9081.20190164
    [7]Ting-tian PANG, Bo YANG, Nan LIU, Xia LIU, Jie QIU, Fu-quan ZHANG. Fixed-jaw Technique in Volumetric Modulated Arc Therapy Plan for Cervical Cancer Radiotherapy[J]. Medical Journal of Peking Union Medical College Hospital, 2014, 5(2): 184-188. DOI: 10.3969/j.issn.1674-9081.2014.02.012
    [8]Bo YANG, Ting-tian PANG, Xia LIU, Xian-song SUN, Wen-bo LI, Ke HU, Jie QIU, Fu-quan ZHANG. Comparison of the Radiation Doses Used in Helical Tomotherapy and Fixed-field Intensity-modulated Radiotherapy for Cervical Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(4): 392-396. DOI: 10.3969/j.issn.1674-9081.2013.04.010
    [9]Jun-fang YAN, Ke HU, Lang YU, Xiao-rong HOU, Jie SHEN, Zhi-kai LIU, Fu-quan ZHANG. Role of Computed Tomography Image Guidance in Two-dimensional Brachytherapy of Cervical Cancer[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(4): 387-391. DOI: 10.3969/j.issn.1674-9081.2013.04.009
    [10]Jie SHEN, Yue MING, Xian-chao TANG, Ke HU, Zhi-kai LIU, Xian-song SUN, Wen-bo LI, Zhi-wei YANG, Fei JIANG, Nan LI, Li-min LI, Fu-quan ZHANG. Radiosensitivity of Cervical Cancer Cells to Different Radiation Doses and Dose Rates[J]. Medical Journal of Peking Union Medical College Hospital, 2013, 4(4): 383-386. DOI: 10.3969/j.issn.1674-9081.2013.04.008

Catalog

    Article Metrics

    Article views (13) PDF downloads (1) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close